Afdhal, Nezam <br/><br/>
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.  [electronic resource] 

 -  The New England journal of medicine  May 2014 
 - 1889-98 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1402454  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Drug Administration Schedule<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--adverse effects<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>RNA, Viral--blood<br/>Ribavirin--adverse effects<br/>Sofosbuvir<br/>Uridine Monophosphate--adverse effects<br/>Viral Load<br/>Young Adult